LA
TMO icon

LBP AM’s Thermo Fisher Scientific TMO Stock Holding History

LBP AM’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104M Sell
211,481
-2,819
-1% -$1.53M 1.42% 14
2025
Q4 		$124M Sell
214,300
-56,190
-21% -$31.8M 1.44% 13
2025
Q3 		$131M Buy
270,490
+9,452
+4% +$4.4M 1.61% 12
2025
Q2 		$106M Buy
261,038
+30,837
+13% +$12.9M 1.49% 12
2025
Q1 		$115M Buy
230,201
+69,507
+43% +$37.6M 1.77% 9
2024
Q4 		$83.6M Buy
160,694
+28,585
+22% +$15.7M 1.13% 16
2024
Q3 		$81.7M Buy
132,109
+130,499
+8,106% +$77.2M 1.23% 16
2024
Q2 		$890K Sell
1,610
-31
-2% -$17.8K 0.04% 285
2024
Q1 		$954K Sell
1,641
-64,443
-98% -$36.2M 0.04% 242
2023
Q4 		$35.1M Sell
66,084
-15,507
-19% -$7.51M 0.77% 29
2023
Q3 		$41.3M Sell
81,591
-9,605
-11% -$5.12M 0.92% 21
2023
Q2 		$47.6M Sell
91,196
-2,520
-3% -$1.36M 1.13% 16
2023
Q1 		$54M Buy
93,716
+3,300
+4% +$1.86M 1.37% 9
2022
Q4 		$49.8M Buy
+90,416
New +$47.9M 1.42% 9

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LBP AM's TMO Position: Q1 2026 in Review

LBP AM reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2026, selling an estimated $1.53M and leaving 211,481 shares worth $104M. The position accounts for 1.42% of the portfolio, ranked #14.

LBP AM first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $131M in Q3 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • LBP AM held 211,481 shares of Thermo Fisher Scientific worth $104M as of Q1 2026.
  • LBP AM sold 2,819 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.53M.
  • Thermo Fisher Scientific made up 1.42% of LBP AM's portfolio in Q1 2026, its #14 holding.
  • LBP AM first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • LBP AM's Thermo Fisher Scientific position peaked at $131M in Q3 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.